Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07218263

AI Platform for Fatigue and Depression Detection

Efficacy of a Novel Web-based Fatigue and Cognitive Assessment Platform in Detecting Fatigue and Depression

Status
Recruiting
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Brijesh Patel · Academic / Other
Sex
All
Age
18 Years – 99 Years
Healthy volunteers

Summary

This observational study evaluates the accuracy of the Okaya AI platform in detecting fatigue and depression in cardiology patients, comparing its assessments to PHQ-9 and Fatigue Assessment Scale scores.

Detailed description

Patients frequently experience fatigue and depression, which are often underdiagnosed due to limitations in traditional screening tools. This study introduces the Okaya platform, a browser-based AI system that analyzes facial and vocal biomarkers collected during conversational check-ins. The platform uses computer vision and natural language processing to extract features such as eye contact, facial affect, pitch, volume, and speech patterns. These features are processed through regression models to generate a composite AI based score. The study aims to validate this score against PHQ-9 and FAS assessments. Participants will complete a single baseline check-in using the Okaya platform and complete standard questionnaires. No interventions will be provided.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTParticipants will complete PHQ-9, FAS, and Okaya assessments.AI-based conversational assessment using facial and vocal features to evaluate fatigue and depression.

Timeline

Start date
2025-12-01
Primary completion
2026-05-01
Completion
2026-05-01
First posted
2025-10-20
Last updated
2026-02-25

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT07218263. Inclusion in this directory is not an endorsement.

AI Platform for Fatigue and Depression Detection (NCT07218263) · Clinical Trials Directory